Pathway Financial Advisers’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-260
| Closed | -$5.73K | – | 199 |
|
|
2024
Q4 | $5.73K | Sell |
260
-4,118
| -94% | -$90.7K | ﹤0.01% | 393 |
|
|
2024
Q3 | $260 | Buy |
4,378
+4,118
| +1,584% | +$245 | ﹤0.01% | 396 |
|
|
2024
Q2 | $3.11K | Hold |
260
| – | – | ﹤0.01% | 415 |
|
|
2024
Q1 | $2.88K | Hold |
260
| – | – | ﹤0.01% | 422 |
|
|
2023
Q4 | $2.25K | Hold |
260
| – | – | ﹤0.01% | 443 |
|
|
2023
Q3 | $1.99K | Buy |
+260
| New | +$1.99K | ﹤0.01% | 453 |
|